Metformin Overdosage

NewsGuard 100/100 Score

Metformin is a biguanide used to treat type 2 diabetes mellitus and most commonly prescribed oral hypoglycemic agent. Metformin is now also used to treat polycystic ovary syndrome and some malignancies. Despite a good safety profile in a majority of patients with diabetes, the risk of metformin-associated lactic acidosis is genuine when safety guidelines are ignored.

metforminImage Credit: Sonis Photography/

Overdoses with metformin are rare but may result in serious consequences. Case reports and small case series of serious toxicity from metformin overdosage can be found in the medical literature, often with the portrayal of extracorporeal methods for the management of the subsequent severe lactic acidosis.

Lactic acidosis can be defined as metabolic acidosis with a blood pH of less than 7.35 and serum lactate of more than 2 mmol per liter. It can occur either with therapeutic metformin dosing (which is rare) or in overdose situations. 0.03 cases of lactic acidosis per 1000 patient-years occur within therapeutic dosing, with a majority of these cases among patients that have contraindications to metformin (such as renal insufficiency).

In overdose situations, lactic acidosis is seen much more habitually, even though the precise incidence is unclear. Lactic acidosis has been observed in 1.6% of metformin exposures reported to poison control centers; nevertheless, merely 10% of these exposures were due to deliberate overdoses.  The incidence of metformin-associated lactic acidosis was 12.8% in a review of poison control center inquiries from Germany.

The minimum reported lethal dose was found in a 42-year-old patient who had a blood metformin level of 188 µg/ml (e.g. therapeutic range level is usually between 0.5–2.5 µg/ml). Although the intake of 35 g of metformin has shown to be lethal, the maximum reported tolerated exposure was in a 70-year-old diabetic patient who ingested 63 grams of metformin.

Signs and symptoms of metformin overdose

Metformin overdose associated with lactic acidosis presents with nonspecific symptoms and includes severe nausea, vomiting, diarrhea, epigastric pain, thirstiness, lost appetite, lethargy and hyperpnoea. Hypotension, hypothermia, acute renal failure, coma and cardiac arrest also represent significant clinical features.

The estimated mortality rate of metformin-associated lactic acidosis is between 30 and 50% but can be high as 80%. The condition occurs most commonly in patients with substantial underlying medical problems (predominantly renal insufficiency). Mortality is not in complete correlation with either metformin or lactate levels.

Hyperglycemia linked to metformin overdose has occasionally been reported, although less common than hypoglycemia. Such hyperglycemia has been linked to acute pancreatitis in several cases of metformin toxicity from both therapeutic dosing and intentional overdose. Another potential complication is the elevated osmolal gap (without exposure to toxic alcohols).

Adequate management

The current treatment approach of the metformin-associated lactic acidosis is volume expansion, intravenous application of sodium bicarbonate, intermittent hemodialysis and high volume continuous venovenous hemodiafiltration with a bicarbonate substitute.

Metformin overdose should be directed with regular monitoring of renal function. Hemodialysis has an important role in and removal of the metformin from the circulation, preventing in turn further acidosis. Hemofiltration is the preferable option for patients who are hemodynamically unstable to tolerate hemodialysis.

The use of sodium bicarbonate is still controversial. Potential disadvantages of using intravenous bicarbonate include excess sodium load, left shift of the oxyhemoglobin dissociation curve, reflex vasodilation after bolus injection and disturbances in serum potassium and calcium levels.


Further Reading

Last Updated: May 18, 2021

Dr. Tomislav Meštrović

Written by

Dr. Tomislav Meštrović

Dr. Tomislav Meštrović is a medical doctor (MD) with a Ph.D. in biomedical and health sciences, specialist in the field of clinical microbiology, and an Assistant Professor at Croatia's youngest university - University North. In addition to his interest in clinical, research and lecturing activities, his immense passion for medical writing and scientific communication goes back to his student days. He enjoys contributing back to the community. In his spare time, Tomislav is a movie buff and an avid traveler.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Meštrović, Tomislav. (2021, May 18). Metformin Overdosage. News-Medical. Retrieved on April 19, 2024 from

  • MLA

    Meštrović, Tomislav. "Metformin Overdosage". News-Medical. 19 April 2024. <>.

  • Chicago

    Meštrović, Tomislav. "Metformin Overdosage". News-Medical. (accessed April 19, 2024).

  • Harvard

    Meštrović, Tomislav. 2021. Metformin Overdosage. News-Medical, viewed 19 April 2024,


  1. Lorelei Rogers Lorelei Rogers Canada says:

    Once I started Sertraline, it interacted with my metformin and blood pressure pills.  Both conditions, hyperglycemia, and hypertension, were stress induced.  The sertraline was releaving the stress, the mechanism I cannot say.  The blood pressure meds, at regular doses for high pressures, were now overdosing, same as metformin.  As a result, I blacked out from hypotensive event due to the overdose.  I also ended up with lactic acidosis, despite having high sugars.  The mechanism I do not understand.  I suffered from the lactic acidiosis until I stopped my metformin, against Drs. advice.  She said, "we dont mess with metformin regimen".  I could not convince an expert Internal Medicine Doctor that my maladies were stress induced and we needed to titrate my meds according to Sertraline increases.  But she would not even consider it.  i stopped the metformin, still have high sugars, but feel so much better. No bed ridden lethargy.  I was almost comatose.

    So please, PTSD and broken sympathetic response messes with metabolism.  No different than Gestational Diabetes.  There should be another classification of Diabetes, Type 3, stress induced.  Which would capture all these anomalies that are not well understood.  In this way, meds can be better managed with a view to stop, not keep going.  thank you!

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Metformin boosts appetite-suppressing metabolite, new study finds